Featured Articles

  1. Building Biotech Champions: Cultivating Breakthroughs In A Dynamic Field 7/10/2025

    Ocugen co-founder and CEO Shankar Musunuri, Ph.D. explains what biotech leaders can learn from the Philadelphia Eagles, an agile team with a championship mindset.

  2. Balanced Disruption: Leading Change In A Family-Owned Pharma Company 7/7/2025

    Driving growth in a family-owned pharma company requires a balance of progress and preservation, writes Merz Therapeutics CEO Stefan König.

  3. Sorriso's Path To Oral Biologics Dosing Is Through The Gut 6/30/2025

    Following positive results from a Phase 1b trial, company leaders describe scaling their yeast expression and spray-drying processes as they prepare for Phase 2.

  4. From Extraterrestrial Life To Cancer Research: Engineering Breakthroughs 6/27/2025

    Sometimes the key to making a breakthrough in research, in any field, is to look at the problem differently than anybody has before, explains Delve Therapeutics cofounder and CTO Mike Flanagan, Ph.D.  

  5. What Life Sciences Gets Right (And Misses) About AI 6/25/2025

    Fear of change is a key limiting factor that is slowing the adoption and value of AI across life sciences. It doesn't have to be that way, writes Anastasia Christianson, Ph.D.

  6. Ten To-Do's For Transitioning From Academia To Entrepreneurship 6/23/2025

    Cuts to federal research funding at universities and research organizations are pushing academic scientists into life sciences entrepreneurship. Experts at Sidley offer tips for the transition.

  7. BIO2025: Sanofi R&D, FDA's Martin Makary, Paying For New Therapies 6/20/2025

    BIO was as busy as ever in Boston this year. With more to come soon, here are a few initial thoughts on three events I attended.

  8. A New Prescription For R&D Tax Credit Reporting 6/20/2025

    New IRS requirements for R&D tax credits are coming into effect for tax year 2025. Life sciences companies should prepare for the changes now, explains Sophia Shah, a CPA at Crowe.

  9. Structuring Cross Border China Biotech 'NewCo' Transactions 6/18/2025

    Proper legal structuring is essential when it comes to transferring Chinese biotech intellectual property and clinical assets to form a U.S.-based 'Newco,' explain experts at Orrick.

  10. Using Generative AI For Smarter, Faster, More Predictive Biopharma Ops 6/16/2025

    Experts at PA Consulting offer case studies and advice for using generative AI to improve biopharma manufacturing, mitigate risk, and comply with emerging AI regulations.